The British government's Medicines & Healthcare Regulatory Agency (MHRA) on Oct. 11 issued a finding that cannabidiol (CBD) has a "restoring, correcting or modifying" effect on "physiological functions." The Independent calls the move "a potential milestone in the campaign to legalise cannabis and bring about evidence-based laws regarding drugs." The review of CBD, a non-psychoactive cannabinoid increasingly studied for its therapeutic value, was undertaken following discussions with MediPen, a London-based company that seeks to market a CBD vaporizer.
Recent comments
13 weeks 6 days ago
18 weeks 3 hours ago
19 weeks 4 days ago
19 weeks 5 days ago
32 weeks 6 hours ago
37 weeks 5 days ago
48 weeks 5 days ago
49 weeks 4 days ago
51 weeks 1 day ago
51 weeks 5 days ago